Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Soluble VEGF isoforms are essential for establishingepiphyseal vascularization and regulating chondrocyte development and survival
Christa Maes, … , Roger Bouillon, Geert Carmeliet
Christa Maes, … , Roger Bouillon, Geert Carmeliet
Published January 15, 2004
Citation Information: J Clin Invest. 2004;113(2):188-199. https://doi.org/10.1172/JCI19383.
View: Text | PDF
Article Bone biology

Soluble VEGF isoforms are essential for establishingepiphyseal vascularization and regulating chondrocyte development and survival

  • Text
  • PDF
Abstract

VEGF is crucial for metaphyseal bone vascularization. In contrast, the angiogenic factors required for vascularization of epiphyseal cartilage are unknown, although this represents a developmentally and clinically important aspect of bone growth. The VEGF gene is alternatively transcribed into VEGF120, VEGF164, and VEGF188 isoforms that differ in matrix association and receptor binding. Their role in bone development was studied in mice expressing single isoforms. Here we report that expression of only VEGF164 or only VEGF188 (in VEGF188/188 mice) was sufficient for metaphyseal development. VEGF188/188 mice, however, showed dwarfism, disrupted development of growth plates and secondary ossification centers, and knee joint dysplasia. This phenotype was at least partly due to impaired vascularization surrounding the epiphysis, resulting in ectopically increased hypoxia and massive chondrocyte apoptosis in the interior of the epiphyseal cartilage. In addition to the vascular defect, we provide in vitro evidence that the VEGF188 isoform alone is also insufficient to regulate chondrocyte proliferation and survival responses to hypoxia. Consistent herewith, chondrocytes in or close to the hypoxic zone in VEGF188/188 mice showed increased proliferation and decreased differentiation. These findings indicate that the insoluble VEGF188 isoform is insufficient for establishing epiphyseal vascularization and regulating cartilage development during endochondral bone formation.

Authors

Christa Maes, Ingrid Stockmans, Karen Moermans, Riet Van Looveren, Nico Smets, Peter Carmeliet, Roger Bouillon, Geert Carmeliet

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Abnormal bone, cartilage, and joint development in VEGF188/188 mice. (a)...
Abnormal bone, cartilage, and joint development in VEGF188/188 mice. (a) Lateral view of WT and VEGF188/188 (188/188) embryos at E16.5. (b) Skeletal preparation of pups at P1.5. (c) Calvaria at P1.5 (top) and P5 (bottom), showing delayed bone growth in the mutants. (d) P1.5 tails, showing reduced size and ossification in VEGF188/188 mice. Asterisks indicate the most distal vertebrae with ossified center. (e) Forelimbs and (f) hind limbs at P1.5. Note incomplete ossification in talus and calcaneus (arrows and insets) and decreased length of the ossified diaphysis, but increased cartilage length in VEGF188/188 bones (bars in f). (g–j) Histological analysis of epiphyseal cartilage of WT and VEGF188/188 mice, showing sections through the center of proximal tibia (ti) and/or distal femur (fe). (g) H&E staining at P1.5, showing large hypocellular region in mutant cartilage. Higher magnification of the boxed area demonstrates abnormal cellular and nuclear morphology. Insets show transverse epiphysis sections, illustrating the restricted central localization of the defect (arrowhead). (h) H&E staining at P5. Asterisks indicate foci of hypertrophied epiphyseal chondrocytes, and arrows point at cartilage invasion by vascular canals in WT. Both features are absent in the mutants, where only perichondrial vessels (arrowhead) are seen adjacent to the cartilage. (i) P14 (toluidine blue) and (j) P28 (safranine O) tibia (left panel) and knee joint (right panels). Note strongly impaired formation of secondary ossification centers, extensive fibrosis and overgrowth of joint ligament tissues, and disruption of articular cartilage surfaces in VEGF188/188 mice. Scale bars: (g) 100 μm; (h–j) 250 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts